The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - Merck Sharp & Dome; PharmaMar
Pembrolizumab (pembro) for recurrent head and neck squamous cell carcinoma (HNSCC): Post hoc analyses of phase 3 KEYNOTE-040 prior radiation treatment (RT) and disease state.
 
Kevin J. Harrington
Honoraria - Amgen; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Pfizer; Replimune
Consulting or Advisory Role - Amgen (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst); Merck Sharp & Dohme; Pfizer (Inst)
Speakers' Bureau - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Ezra E.W. Cohen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; EMD Serono; Human Longevity, Inc; Incyte; Mavu Pharmaceutical; Merck; Nanobiotix; Pfizer
 
Denis Soulieres
Honoraria - AstraZeneca; Bristol-Myers Squibb; Ipsen; Merck; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - Ipsen; Merck; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
José Dinis
No Relationships to Disclose
 
Lisa F. Licitra
Consulting or Advisory Role - Amgen and Nanobiotics Sa; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Debiopharm Group; Doxapharma; Eisai; Health & Life srl; Immuno-Oncology Hub; Incyte; Ipsen; Kura Oncology; Merck Serono; MSD; Novartis; Roche; SOBI
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Eisai (Inst); Exelixis (Inst); IRX Therapeutics (Inst); Medpace (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Roche (Inst)
Expert Testimony - Bayer; Doxapharma; GlaxoSmithKline; Health & Life; Ipsen; Kura Oncology; Merck Serono; MSD
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Debiopharm Group; Merck Serono; MSD; SOBI
 
Myung-Ju Ahn
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dome; Ono Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dome; Ono Pharmaceutical
 
Ainara Soria
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Roche; Sanofi
Expert Testimony - Bristol-Myers Squibb; Merck; Novartis; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Novartis; Roche
 
Jean-Pascal H. Machiels
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Debiopharm Group; Incyte; Innate Pharma; Janssen; Merck Serono; Merck Sharp & Dohme; Nanobiotix; Novartis; Pfizer; Roche
Research Funding - Bayer; Janssen; Novartis; Sanofi
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD; Pfizer
 
Nicolas Mach
Stock and Other Ownership Interests - MaxiVax
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dome; Roche
Research Funding - MaxiVax
 
Ranee Mehra
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Innate Pharma
Research Funding - Genentech
Travel, Accommodations, Expenses - Mirati Therapeutics
 
Barbara Burtness
Consulting or Advisory Role - Aduro Biotech; Alligator Bioscience; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; CUE Biopharma; Debiopharm Group; Genentech/Roche; GlaxoSmithKline; MedImmune; Merck; VentiRx
Travel, Accommodations, Expenses - Boehringer Ingelheim; Debiopharm Group; Merck
 
Jianxin Lin
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Jonathan D. Cheng
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Ramona F. Swaby
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Christophe Le Tourneau
Honoraria - Amgen; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dome; Nanobiotix; Novartis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dome; Nanobiotix; Novartis
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dome